These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 25489803

  • 1. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
    Halim MA, Al-Otaibi T, Gheith O, Zkaria Z, Mosaad A, Said T, Nair P, Nampoory N.
    Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
    [Abstract] [Full Text] [Related]

  • 2. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
    Halim MA, Al-Otaibi T, Gheith O, Mosaad A, Zakaria Z, Said T, Nair P, Nampoory NM.
    Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
    Shah T, Vu D, Naraghi R, Campbell A, Min D.
    Clin Transpl; 2014 Feb; ():109-16. PubMed ID: 26281134
    [Abstract] [Full Text] [Related]

  • 4. Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
    Jaw J, Hill P, Goodman D.
    Nephrology (Carlton); 2017 Apr; 22(4):326-329. PubMed ID: 28247521
    [Abstract] [Full Text] [Related]

  • 5. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
    Pape L, Tönshoff B, Hirsch HH, Members of the Working Group ‘Transplantation’ of the European Society for Paediatric Nephrology.
    Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
    Al-Raisi F, Mohsin N, Kamble P.
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.
    Lee HM, Jang IA, Lee D, Kang EJ, Choi BS, Park CW, Choi YJ, Yang CW, Kim YS, Chung BH.
    Korean J Intern Med; 2015 Nov; 30(6):865-72. PubMed ID: 26552462
    [Abstract] [Full Text] [Related]

  • 11. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year.
    Wojciechowski D, Chanda R, Chandran S, Lee B, Webber A, Macaraig M, Tomlanovich S, Vincenti F.
    Transplantation; 2012 Dec 15; 94(11):1117-23. PubMed ID: 23060281
    [Abstract] [Full Text] [Related]

  • 12. BK Virus in Kidney Transplant: Current Concepts, Recent Advances, and Future Directions.
    Sharma R, Tzetzo S, Patel S, Zachariah M, Sharma S, Melendy T.
    Exp Clin Transplant; 2016 Aug 15; 14(4):377-84. PubMed ID: 27267780
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
    Knight RJ, Gaber LW, Patel SJ, DeVos JM, Moore LW, Gaber AO.
    Transplantation; 2013 Apr 15; 95(7):949-54. PubMed ID: 23545506
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome.
    Canivet C, Rostaing L, Galvani S, Böhler T, Gandia P, Mengelle C, Guilbeau-Frugier C, Thomsen M, Salvayre R, Negre-Salvayre A, Kamar N.
    Int Immunopharmacol; 2009 Aug 15; 9(9):1131-6. PubMed ID: 19446045
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human leukocyte antigen Cw7-mediated protection against polyoma BK virus in renal transplant recipients who received grafts from antigen-positive donors.
    Gheith O, Al-Otaibi T, Zakaria Z, Abdel Halim M, Nampoory N.
    Exp Clin Transplant; 2015 Apr 15; 13 Suppl 1():383-7. PubMed ID: 25894195
    [Abstract] [Full Text] [Related]

  • 20. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC, Bodson-Clermont P, St-Louis G, Pâquet MR, Girardin C, Fortin MC, Cardinal H, Hébert MJ, Lévesque R, Renoult E.
    Transpl Infect Dis; 2017 Jun 15; 19(3):. PubMed ID: 28207975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.